I think it would be helpful if there was some kind of acknowledgement that these are people that are living with a disease, and they've taken a treatment for that disease, and there is no shame in that they're improving their overall health. Evers said people need to move away from calling GLP-1 drugs weight-loss medications and instead call them obesity medications, which gives them an accurate medical context
Maintaining adequate protein, complex carbohydrate, and fluid intake, eating smaller frequent meals, pacing physical activity, and avoiding alcohol can all help reduce fatigue
The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average
For diabetes management , the most important metric is blood glucose control
In the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RA use was associated with lower risk among patients with recent psychiatric history, and no difference among patient without recent psychiatric history
People often report that their measurements tell a more dramatic story than their weight, because the fat being lost is dense and centrally located